With respect to NGAL, this is a protein of the lipocalin family that has been observed to be increased in chronic renal diseases and acute renal damage; it has also been implemented as a biomarker of early effect to renal damage in children and adults [45]. Here, LCN2 is linked to chronic kidney disease.